|
|
Xenobiotic Detection Systems, Inc |
||||
| About XDS | Dioxin Toxicity | Publications | Glossary | Links page | |
| Products | Endocrine Disruptors | News Releases | Site Map | Contact Us | |
| Patents, Certifications |
| Principal Scientists |
Mission Statement
XDS exists to develop and advance commercial acceptance of biological methods that will facilitate assessment of environmental and human health risks
History
Xenobiotic Detection Systems (XDS) was started in 1995 by Drs. George C. Clark and Michael S. Denison. In 1997 XDS received major Research and Development funding from the National Institutes of Health.
In 1998 XDS was awarded a patent for its proprietary CALUX® (Chemically-Activated LUciferase gene eXpression cell bioassay system) assay for dioixn-like chemicals.
Further improvements have been made on this assay and now XDS offers the DIPS-CALUX® assay, which is the "Proven best bioassay available at this time."